Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
-0.67%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$8.92B
AUM Growth
+$750M
(+9.2%)
Cap. Flow
+$893M
Cap. Flow
% of AUM
10.01%
Top 10 Holdings %
Top 10 Hldgs %
10.22%
Holding
2,098
New
530
Increased
477
Reduced
405
Closed
483
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$127M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 3 |
Microsoft
MSFT
|
+$75.4M |
| 4 |
Visa
V
|
+$64.1M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$62.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$61.6M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$50.4M |
| 5 |
Amgen
AMGN
|
+$46.7M |
Sector Composition
| 1 | Technology | 19% |
| 2 | Industrials | 12.06% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Healthcare | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Terns Pharmaceuticals
TERN
$654M
| $107K | ﹤0.01% |
+15,753
| New | +$107K |
|
|
BLUE
1402
DELISTED
bluebird bio
BLUE
| $106K | ﹤0.01% |
5,398
| – | – |
|
1403
uniQure
QURE
$959M
| $105K | ﹤0.01% |
23,479
-174
| -0.7% | -$780 |
|
1404
Stem
STEM
$111M
| $102K | ﹤0.01% |
4,580
-8,589
| -65% | -$191K |
|
|
IGMS
1405
DELISTED
IGM Biosciences
IGMS
| $99.9K | ﹤0.01% |
+14,537
| New | +$99.9K |
|
|
NGD
1406
New Gold Inc
NGD
$5.14B
| $98.6K | ﹤0.01% |
+50,559
| New | +$98.6K |
|
1407
OppFi
OPFI
$289M
| $97.7K | ﹤0.01% |
28,822
-26,947
| -48% | -$91.4K |
|
1408
IAMGOLD
IAG
$6.27B
| $94.6K | ﹤0.01% |
+25,229
| New | +$94.6K |
|
1409
Alector
ALEC
$287M
| $92.3K | ﹤0.01% |
+20,337
| New | +$92.3K |
|
1410
Holley
HLLY
$360M
| $86.9K | ﹤0.01% |
24,284
-97,039
| -80% | -$347K |
|
1411
Weibo
WB
$2.98B
| $83.8K | ﹤0.01% |
+10,911
| New | +$83.8K |
|
1412
Transocean
RIG
$3.06B
| $82K | ﹤0.01% |
+15,320
| New | +$82K |
|
|
TGB
1413
Taseko Mines
TGB
$1.08B
| $78.4K | ﹤0.01% |
+32,008
| New | +$78.4K |
|
1414
ProKidney
PROK
$292M
| $75K | ﹤0.01% |
+30,484
| New | +$75K |
|
|
LAR
1415
Lithium Argentina AG
LAR
$513M
| $72K | ﹤0.01% |
22,491
-50,192
| -69% | -$161K |
|
1416
Nektar Therapeutics
NKTR
$916M
| $70.8K | ﹤0.01% |
3,806
| – | – |
|
1417
Senseonics Holdings
SENS
$357M
| $69.6K | ﹤0.01% |
174,383
| – | – |
|
1418
DocGo
DCGO
$148M
| $69K | ﹤0.01% |
22,329
| – | – |
|
1419
Seer Inc
SEER
$117M
| $66.8K | ﹤0.01% |
39,783
-45,688
| -53% | -$76.8K |
|
1420
Design Therapeutics
DSGN
$349M
| $66.5K | ﹤0.01% |
19,865
-5,462
| -22% | -$18.3K |
|
1421
loanDepot
LDI
$735M
| $65.5K | ﹤0.01% |
39,699
-68,385
| -63% | -$113K |
|
1422
Ventyx Biosciences
VTYX
$169M
| $65K | ﹤0.01% |
28,133
+8,790
| +45% | +$20.3K |
|
1423
ALX Oncology
ALXO
$62.7M
| $60.9K | ﹤0.01% |
10,098
-10,142
| -50% | -$61.2K |
|
1424
Taysha Gene Therapies
TSHA
$887M
| $59.7K | ﹤0.01% |
+26,634
| New | +$59.7K |
|
|
GAN
1425
DELISTED
GAN Ltd
GAN
| $59.6K | ﹤0.01% |
40,436
| – | – |
|